Profile

Dr. Jovanovic is an economist with over 20 years of experience providing economic and statistical analyses in litigation, government investigations, and regulatory proceedings. He has deep expertise in consumer protection matters and provides economic analysis in false advertising, product defects, consumer finance, and data privacy litigation.

Dr. Jovanovic has served as a testifying and consulting expert on a wide array of cases that have required sophisticated econometric analyses, including the analysis of class certification, liability, and damages issues in consumer and securities class actions, false advertising, data privacy and Lanham Act matters. He has extensive experience analyzing the direct selling compensation models of nutrition, supplement, cosmetics, and other life sciences companies.

Dr. Jovanovic has provided testimony before the SEC, the International Chamber of Commerce’s International Court of Arbitration, the American Arbitration Association, and various federal and state courts.

A significant focus of Dr. Jovanovic’s work has involved assisting clients in responding to formal investigations and requests for data and analyses from regulatory entities such as the Federal Trade Commission (FTC), the US Securities and Exchange Commission (SEC), offices of State Attorneys General, and self-regulating organizations such as the Financial Industry Regulatory Authority (FINRA), and US stock exchanges.

Dr. Jovanovic’s research has been published in a number of academic and professional journals. He has lectured on economic issues in a variety of continuing legal education forums and previously taught graduate econometrics courses at New York University and Johns Hopkins University.

Previous Experience

  • Principal, The Brattle Group
  • Partner, Bates White
  • Senior Consultant, NERA Economic Consulting
  • Principal, Econ One Research

Insights & News

Publications

  • ABA Antitrust Law Section’s Economics Committee | 11.14.2024

    “Dark patterns” is a term used to describe potentially deceptive app or website designs that could manipulate consumers to make choices they would otherwise not make.

  • Published Article, Law360 | 08.09.2024

    On April 30, the FTC published updated business guidance concerning multilevel marketers, or MLMs. This 2024 guidance details the current principles and practices that the FTC claims to consider in its assessment of whether an MLM is offering an unlawful compensation structure and operating as a pyramid scheme.

  • Published Article, Securities Regulation Law Journal | 12.28.2023
  • Published Article, Law360 | 06.28.2023

    While the direct-selling world was awaiting U.S. District Judge Barbara Lynn's decision in Federal Trade Commission v. Neora LLC, in which the FTC alleged that Neora operated an illegal pyramid scheme, the FTC v. Noland case largely flew under the radar.

Edgeworth Insights

  • Blog, 11.12.2024

    “Dark patterns” is a term used to describe potentially deceptive app or website designs that could manipulate consumers to make choices they would otherwise not make.

  • Blog, 08.09.2024

    On April 30, the FTC published updated business guidance concerning multilevel marketers, or MLMs. This 2024 guidance details the current principles and practices that the FTC claims to consider in its assessment of whether an MLM is offering an unlawful compensation structure and operating as a pyramid scheme.

  • Blog, 02.20.2024

    Our research into settlements in data breach class actions suggests that settlements in these matters may be less informative for assessing the value of a case as whole, as well as the value of the data exposed in the cyberattack.

  • Blog, 10.05.2023

    U.S. District Judge Barbara Lynn's decision in Federal Trade Commission v. Neora LLC in the U.S. District Court for the Northern District of Texas last week marks a landmark victory for the direct selling industry.[1]

  • Blog, 08.08.2023

    Biotechnology companies Natera and CareDx have been engaged in a prolonged legal battle regarding the validity of patents covering methods of cell-free DNA analysis for noninvasive monitoring of organ transplant rejection. The case has been lauded by the legal community as the “last chance for diagnostic patents” to be reviewed by the Supreme Court.[1]

Speaking Engagements

News

Education

Dr. Jovanovic received his PhD in economics from Texas A&M University, his MA in economics from Central European University, and his BS in economics from the University of Belgrade. 

Jump to Page

This website uses cookies to improve functionality and performance. By continuing to use this website, you agree to the use of cookies in accordance with our Privacy Policy.  If you are a California resident, read our California Information Practices.